C M Croce

发表

Crystal structure of MTCP-1: implications for role of TCL-1 and MTCP-1 in T cell malignancies.

C. Croce, I. Weber, R. Harrison, 1998, Proceedings of the National Academy of Sciences of the United States of America.

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways

Meng Li, C. Croce, M. Ivan, 2011, Oncogene.

Extensive modulation of a set of microRNAs in primary glioblastoma.

G. Maira, C. Croce, M. Ferracin, 2005, Biochemical and biophysical research communications.

Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma.

J Erikson, C. Croce, K. Nishikura, 1983, Science.

Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.

C. Croce, S. Sabbioni, M. Negrini, 1994, Cancer research.

MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer

Y Yang, A. Schetter, R. Stephens, 2013, Oncogene.

A Human REV7 Homolog That Interacts with the Polymerase ζ Catalytic Subunit hREV3 and the Spindle Assembly Checkpoint Protein hMAD2*

C. Croce, Y. Murakumo, R. Fishel, 2000, The Journal of Biological Chemistry.

huASH1 protein, a putative transcription factor encoded by a human homologue of the Drosophila ash1 gene, localizes to both nuclei and cell-cell tight junctions.

C. Croce, B. Geiger, F. Bullrich, 2000, Proceedings of the National Academy of Sciences of the United States of America.

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

C. Croce, G. Calin, R. Aqeilan, 2010, Cell Death and Differentiation.

Molecular genetics of human B- and T-cell neoplasia.

J Erikson, C. Croce, F. Haluska, 1986, Cold Spring Harbor symposia on quantitative biology.

MicroRNAs and chromosomal abnormalities in cancer cells

C. Croce, G. Calin, G A Calin, 2006, Oncogene.

Bcl2 is the guardian of microtubule integrity.

C. Croce, S. Haldar, C M Croce, 1997, Cancer research.

Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.

J C Reed, C. Croce, John Calvin Reed, 1990, Cancer research.

Chromosome walking on the TCL1 locus involved in T-cell neoplasia.

M. Isobe, G. Russo, C. Croce, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11.

C. Croce, S. Sabbioni, M. Negrini, 1994, Cancer research.

Nucleotide sequence analysis of human abl and bcr-abl cDNAs.

C. Croce, C. Marcelle, E. Canaani, 1989, Oncogene.

Structure and expression of the human FHIT gene in normal and tumor cells.

C. Croce, M. Negrini, R. Baffa, 1997, Cancer research.

Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.

C. Croce, A. Rosenberg, M. Negrini, 1995, Cancer research.

Tcl1 enhances Akt kinase activity and mediates its nuclear translocation.

C M Croce, M Tresini, S Malstrom, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma.

J Erikson, P. Nowell, C. Croce, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Identification of the TCL1 gene involved in T-cell malignancies.

M. Isobe, G. Russo, C. Croce, 1994, Proceedings of the National Academy of Sciences of the United States of America.

The role of the FHIT/FRA3B locus in cancer.

L. D. Barnes, C. Croce, K. Huebner, 1998, Annual review of genetics.

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells

G. Mills, X. Liu, C. Croce, 2010, Cell Death and Differentiation.

Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues.

C D Baroni, E Pescarmona, G. Russo, 2000, Cancer research.

Regulation of microRNA expression by HMGA1 proteins

C. Croce, R. Visone, A. Fusco, 2016, Oncogene.

The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex.

O. Rozenblatt-Rosen, C. Croce, T. Rozovskaia, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Muir-Torre-like syndrome in Fhit-deficient mice.

C. Croce, R. Mancini, K. Huebner, 2000, Proceedings of the National Academy of Sciences of the United States of America.

MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia

C. Croce, Chang-gong Liu, S. Volinia, 2007, Oncogene.

Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans.

Y. Pekarsky, C. Croce, M. Campiglio, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas.

C. Croce, K. Huebner, L. Gissmann, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Chromosomal locations of mouse immunoglobulin genes.

C. Croce, K. Huebner, R. Perry, 1978, Proceedings of the National Academy of Sciences of the United States of America.

The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.

C. Croce, H. Ishii, R. Baffa, 1999, Proceedings of the National Academy of Sciences of the United States of America.

microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer

C. Croce, M. Negrini, G. Nuovo, 2011, Oncogene.

Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.

L. D. Barnes, C. Croce, K. Huebner, 1998, Proceedings of the National Academy of Sciences of the United States of America.